<DOC>
	<DOC>NCT00150371</DOC>
	<brief_summary>The objective of this study is to assess the effectiveness of an atorvastatin treatment regimen involving starting doses between 10 and 80 mg, followed by a single-step titration (except for subjects started at 80mg), if required</brief_summary>
	<brief_title>Canadians Achieve Cholesterol Targets Fast With Atorvastatin Stratified Titration</brief_title>
	<detailed_description />
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<criteria>Age 30 to 79 years old Triglyceride level 6.8 mmol/L at screening LDLC of 5.7 mmol/L at screening Pregnant or lactating women, or women of childbearing potential not using an acceptable method of contraception. The latter are defined as: abstinence, surgical sterilization, oral contraceptives for at least 3 cycles, intrauterine device, implant, depot injection, or barrier method in conjunction with contraceptive foam or jelly. Subjects whose blood cholesterol levels are controlled (LDLC targets) with statins other than atorvastatin Subjects receiving statin doses higher than the following: 1040mg for simvastatin , 2040mg for fluvastatin, pravastatin and lovastatin and 1020 mg for rosuvastatin. Subjects already treated with atorvastatin at the time of screening are not eligible unless atorvastatin has been discontinued at least 2 months prior to screening Subjects receiving 2 or more lipid lowering agents are excluded (statins + resins or fibrates or niacin or fish oils)</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>April 2007</verification_date>
	<keyword>(D006937)</keyword>
</DOC>